Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus. - Scharnagl,H.; Winkler,K.; Mantz,S.; Baumstark,MW.; Wieland,H.; Marz,W. (Exp Clin Endocrinol Diabetes, 2004)